ID   ZNF16_HUMAN             Reviewed;         682 AA.
AC   P17020; B3KXM4; D3DWP2; Q45SH7; Q96FG0; Q9NRA4;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 3.
DT   28-JUN-2023, entry version 211.
DE   RecName: Full=Zinc finger protein 16;
DE   AltName: Full=Zinc finger protein KOX9;
GN   Name=ZNF16; Synonyms=HZF1, KOX9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INDUCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow;
RX   PubMed=16628192; DOI=10.1038/sj.leu.2404212;
RA   Peng H., Du Z.W., Zhang J.W.;
RT   "Identification and characterization of a novel zinc finger protein (HZF1)
RT   gene and its function in erythroid and megakaryocytic differentiation of
RT   K562 cells.";
RL   Leukemia 20:1109-1116(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 461-516.
RC   TISSUE=Lymphoid tissue;
RX   PubMed=2288909;
RA   Thiesen H.-J.;
RT   "Multiple genes encoding zinc finger domains are expressed in human T
RT   cells.";
RL   New Biol. 2:363-374(1990).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-487, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   FUNCTION.
RX   PubMed=19763908; DOI=10.1007/s12033-009-9210-8;
RA   Deng M.J., Li X.B., Peng H., Zhang J.W.;
RT   "Identification of the trans-activation domain and the nuclear location
RT   signals of human zinc finger protein HZF1 (ZNF16).";
RL   Mol. Biotechnol. 44:83-89(2010).
RN   [8]
RP   INDUCTION.
RX   PubMed=21468593; DOI=10.3892/mmr.2011.465;
RA   Liu X., Jin E.Z., Zhi J.X., Li X.Q.;
RT   "Identification of HZF1 as a novel target gene of the MEF2 transcription
RT   factor.";
RL   Mol. Med. Report. 4:465-469(2011).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH INCA1.
RX   PubMed=21874239; DOI=10.3892/mmr.2011.564;
RA   Li X.B., Chen J., Deng M.J., Wang F., Du Z.W., Zhang J.W.;
RT   "Zinc finger protein HZF1 promotes K562 cell proliferation by interacting
RT   with and inhibiting INCA1.";
RL   Mol. Med. Report. 4:1131-1137(2011).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-253, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Acts as a transcriptional activator. Promotes cell
CC       proliferation by facilitating the cell cycle phase transition from the
CC       S to G2/M phase. Involved in both the hemin- and phorbol myristate
CC       acetate (PMA)-induced erythroid and megakaryocytic differentiation,
CC       respectively. Also plays a role as an inhibitor of cell apoptosis.
CC       {ECO:0000269|PubMed:16628192, ECO:0000269|PubMed:19763908,
CC       ECO:0000269|PubMed:21874239}.
CC   -!- SUBUNIT: Interacts with INCA1; the interaction inhibits INCA1 activity
CC       and induces the cell cycle process. {ECO:0000269|PubMed:21874239}.
CC   -!- INTERACTION:
CC       P17020; P29972: AQP1; NbExp=3; IntAct=EBI-3921553, EBI-745213;
CC       P17020; Q9NVQ4-2: FAIM; NbExp=3; IntAct=EBI-3921553, EBI-12039347;
CC       P17020; Q0VD86: INCA1; NbExp=2; IntAct=EBI-3921553, EBI-6509505;
CC       P17020; Q9UFB7: ZBTB47; NbExp=3; IntAct=EBI-3921553, EBI-7781767;
CC       P17020; Q9NP64: ZCCHC17; NbExp=3; IntAct=EBI-3921553, EBI-746345;
CC       P17020; Q8IZC7: ZNF101; NbExp=3; IntAct=EBI-3921553, EBI-5278328;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16628192}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:16628192}.
CC   -!- INDUCTION: Up-regulated by hemin during erythroid differentiation. Up-
CC       regulated by phorbol myristate acetate (PMA) during megakaryocytic
CC       differentiation. Up-regulated by the transcriptional activator MEF2A.
CC       {ECO:0000269|PubMed:16628192, ECO:0000269|PubMed:21468593}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF75235.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAZ20773.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF244088; AAF75235.1; ALT_INIT; mRNA.
DR   EMBL; DQ117529; AAZ20773.1; ALT_INIT; mRNA.
DR   EMBL; AK127625; BAG54536.1; -; mRNA.
DR   EMBL; CH471162; EAW82027.1; -; Genomic_DNA.
DR   EMBL; CH471162; EAW82028.1; -; Genomic_DNA.
DR   EMBL; BC010996; AAH10996.2; -; mRNA.
DR   EMBL; X52340; CAA36566.1; -; mRNA.
DR   CCDS; CCDS6437.1; -.
DR   PIR; I37977; I37977.
DR   RefSeq; NP_001025147.2; NM_001029976.2.
DR   RefSeq; NP_008889.2; NM_006958.2.
DR   RefSeq; XP_005272398.1; XM_005272341.2.
DR   RefSeq; XP_011515600.1; XM_011517298.1.
DR   AlphaFoldDB; P17020; -.
DR   SMR; P17020; -.
DR   BioGRID; 113395; 40.
DR   IntAct; P17020; 38.
DR   STRING; 9606.ENSP00000276816; -.
DR   iPTMnet; P17020; -.
DR   PhosphoSitePlus; P17020; -.
DR   BioMuta; ZNF16; -.
DR   DMDM; 68846743; -.
DR   EPD; P17020; -.
DR   jPOST; P17020; -.
DR   MassIVE; P17020; -.
DR   MaxQB; P17020; -.
DR   PaxDb; P17020; -.
DR   PeptideAtlas; P17020; -.
DR   ProteomicsDB; 53416; -.
DR   Antibodypedia; 15018; 122 antibodies from 18 providers.
DR   DNASU; 7564; -.
DR   Ensembl; ENST00000276816.8; ENSP00000276816.4; ENSG00000170631.15.
DR   Ensembl; ENST00000394909.7; ENSP00000378369.2; ENSG00000170631.15.
DR   Ensembl; ENST00000611477.1; ENSP00000484504.1; ENSG00000170631.15.
DR   GeneID; 7564; -.
DR   KEGG; hsa:7564; -.
DR   MANE-Select; ENST00000394909.7; ENSP00000378369.2; NM_006958.3; NP_008889.2.
DR   UCSC; uc003zet.3; human.
DR   AGR; HGNC:12947; -.
DR   CTD; 7564; -.
DR   GeneCards; ZNF16; -.
DR   HGNC; HGNC:12947; ZNF16.
DR   HPA; ENSG00000170631; Low tissue specificity.
DR   MIM; 601262; gene.
DR   neXtProt; NX_P17020; -.
DR   OpenTargets; ENSG00000170631; -.
DR   PharmGKB; PA37530; -.
DR   VEuPathDB; HostDB:ENSG00000170631; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000163050; -.
DR   HOGENOM; CLU_002678_57_1_1; -.
DR   InParanoid; P17020; -.
DR   OMA; EERPHLY; -.
DR   OrthoDB; 5340727at2759; -.
DR   PhylomeDB; P17020; -.
DR   TreeFam; TF337005; -.
DR   PathwayCommons; P17020; -.
DR   SignaLink; P17020; -.
DR   BioGRID-ORCS; 7564; 13 hits in 1177 CRISPR screens.
DR   ChiTaRS; ZNF16; human.
DR   GeneWiki; ZNF16; -.
DR   GenomeRNAi; 7564; -.
DR   Pharos; P17020; Tbio.
DR   PRO; PR:P17020; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P17020; protein.
DR   Bgee; ENSG00000170631; Expressed in oocyte and 149 other tissues.
DR   ExpressionAtlas; P17020; baseline and differential.
DR   Genevisible; P17020; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0072707; P:cellular response to sodium dodecyl sulfate; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:1901989; P:positive regulation of cell cycle phase transition; IDA:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IDA:UniProtKB.
DR   GO; GO:0045654; P:positive regulation of megakaryocyte differentiation; IMP:UniProtKB.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 17.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24379; KRAB AND ZINC FINGER DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR24379:SF80; SIMILAR TO ZINC FINGER PROTEIN 84 (HPF2); 1.
DR   Pfam; PF00096; zf-C2H2; 15.
DR   SMART; SM00355; ZnF_C2H2; 17.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 9.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 15.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 17.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Cell cycle; Cell division; DNA-binding;
KW   Isopeptide bond; Metal-binding; Mitogen; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..682
FT                   /note="Zinc finger protein 16"
FT                   /id="PRO_0000047338"
FT   ZN_FING         209..231
FT                   /note="C2H2-type 1; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         237..259
FT                   /note="C2H2-type 2; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         265..287
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         293..315
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         321..343
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         349..371
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         377..399
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         405..427
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         433..455
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         461..483
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         489..511
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         517..539
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         545..567
FT                   /note="C2H2-type 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         573..595
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         601..623
FT                   /note="C2H2-type 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         629..651
FT                   /note="C2H2-type 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         657..679
FT                   /note="C2H2-type 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          62..210
FT                   /note="Necessary for transcription activation"
FT   REGION          268..393
FT                   /note="Required for nuclear localization"
FT   REGION          341..373
FT                   /note="Required for nuclear localization"
FT   REGION          473..503
FT                   /note="Required for nuclear localization"
FT   MOD_RES         487
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   CROSSLNK        253
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         105
FT                   /note="E -> K (in dbSNP:rs3735784)"
FT                   /id="VAR_024193"
FT   VARIANT         227
FT                   /note="R -> H (in dbSNP:rs3735786)"
FT                   /id="VAR_024194"
SQ   SEQUENCE   682 AA;  76472 MW;  3D4FA38552001430 CRC64;
     MPSLRTRREE AEMELSVPGP SPWTPAAQAR VRDAPAVTHP GSAACGTPCC SDTELEAICP
     HYQQPDCDTR TEDKEFLHKE DIHEDLESQA EISENYAGDV SQVPELGDLC DDVSERDWGV
     PEGRRLPQSL SQEGDFTPAA MGLLRGPLGE KDLDCNGFDS RFSLSPNLMA CQEIPTEERP
     HPYDMGGQSF QHSVDLTGHE GVPTAESPLI CNECGKTFQG NPDLIQRQIV HTGEASFMCD
     DCGKTFSQNS VLKNRHRSHM SEKAYQCSEC GKAFRGHSDF SRHQSHHSSE RPYMCNECGK
     AFSQNSSLKK HQKSHMSEKP YECNECGKAF RRSSNLIQHQ RIHSGEKPYV CSECGKAFRR
     SSNLIKHHRT HTGEKPFECG ECGKAFSQSA HLRKHQRVHT GEKPYECNDC GKPFSRVSNL
     IKHHRVHTGE KPYKCSDCGK AFSQSSSLIQ HRRIHTGEKP HVCNVCGKAF SYSSVLRKHQ
     IIHTGEKPYR CSVCGKAFSH SSALIQHQGV HTGDKPYACH ECGKTFGRSS NLILHQRVHT
     GEKPYECTEC GKTFSQSSTL IQHQRIHNGL KPHECNQCGK AFNRSSNLIH HQKVHTGEKP
     YTCVECGKGF SQSSHLIQHQ IIHTGERPYK CSECGKAFSQ RSVLIQHQRI HTGVKPYDCA
     ACGKAFSQRS KLIKHQLIHT RE
//
